Nathan Lakey is President and Chief Executive Officer and a member of the Board of Directors. He was regionally recognized with the top 40 under 40 award (2004 St. Louis), presented with the governor’s top technology award (2005 Missouri) and currently serves on the Patient Care Committee of the Board of Missouri Baptist Hospital. Mr. Lakey was founding principal of Orion Genomics where he has served as President and Chief Executive Officer since June 2000. Mr. Lakey has more than 20 years of experience in genomics. Prior to the founding of Orion Genomics, he was Director of DNA Sequencing at Millennium Pharmaceuticals, Inc., in Cambridge, Massachusetts (1994-98), where he built and operated the DNA sequencing platform for Millennium and helped form three strategic business units – Millennium Predictive Medicine, Millennium Biotherapeutics and Cereon Inc. Before joining Millennium, Mr. Lakey held various positions with Molecular Dynamics (Sunnyvale, CA), Ambion Inc (Austin, TX) and Harvard Medical School, Department of Genetics, in the laboratory of George Church. Mr. Lakey received a B.A. in Biochemistry from the University of Texas (Austin), and an MBA from Washington University Olin School of Business (St. Louis) where he received the C. William Emory Executive MBA Award. Mr. Lakey holds 3 issued US patents and multiple pending applications.